News

Hepatitis B virus infections can progress from an acute ... approximately 74% base pairing to form an unbranched rod-like structure. The genome sequence shows no homology to the 3300-nucleotide ...
Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.
HBV=hepatitis B virus. HBVDR=HBV drug resistance ... The WHO global viral hepatitis reporting framework could then provide a structure for monitoring the quality of HBV service delivery, through the ...
What is an amniocentesis? Amniocentesis (sometimes called "amnio") is a test in which your doctor takes a small sample of ...
In their research, the team has programmed it to bind to the protein of the virus that causes COVID ... other viruses like influenza, HIV or hepatitis B, Wang said. And, it could be used for ...
Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...
Currently, there is no feline vaccine for the hepatitis B virus, and the hepatitis B vaccine for humans is highly toxic to ...
Fatigue and yellowing eyes may signal hepatitis, a serious liver issue. Learn the symptoms, causes, prevention, and available ...
Hepatitis B is a liver inflammation caused by the hepatitis B virus (HBV). It is the second-leading infectious cause of death globally after tuberculosis. Prevention of mother-to-child ...
An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.
Chronic hepatitis B (CHB) is a long-term infection of the liver caused by the hepatitis B virus (HBV). While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the ...
Shares of Precision BioSciences DTIL rallied 23.8% on Tuesday after the company’s announcement that the FDA has granted Fast Track designation to PBGENE-HBV. This is DTIL’s lead, fully owned ...